Does TECLISTAMAB Cause Febrile bone marrow aplasia? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Febrile bone marrow aplasia have been filed in association with TECLISTAMAB (TECVAYLI). This represents 0.9% of all adverse event reports for TECLISTAMAB.
11
Reports of Febrile bone marrow aplasia with TECLISTAMAB
0.9%
of all TECLISTAMAB reports
11
Deaths
11
Hospitalizations
How Dangerous Is Febrile bone marrow aplasia From TECLISTAMAB?
Of the 11 reports, 11 (100.0%) resulted in death, 11 (100.0%) required hospitalization, and 11 (100.0%) were considered life-threatening.
Is Febrile bone marrow aplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB Cause?
Cytokine release syndrome (257)
Pneumonia (101)
Plasma cell myeloma (100)
Immune effector cell-associated neurotoxicity syndrome (99)
Pyrexia (86)
Covid-19 (82)
Infection (58)
Drug ineffective (52)
Neutropenia (48)
Sepsis (48)
What Other Drugs Cause Febrile bone marrow aplasia?
VINCRISTINE (912)
METHOTREXATE (880)
CYCLOPHOSPHAMIDE (839)
CYTARABINE (733)
PEGASPARGASE (668)
DOXORUBICIN (623)
DEXAMETHASONE (555)
CARBOPLATIN (440)
ETOPOSIDE (413)
HYDROCORTISONE (379)
Which TECLISTAMAB Alternatives Have Lower Febrile bone marrow aplasia Risk?
TECLISTAMAB vs TECLISTAMAB-CQYV
TECLISTAMAB vs TEDIZOLID
TECLISTAMAB vs TEDUGLUTIDE
TECLISTAMAB vs TEDUGLUTIDE\WATER
TECLISTAMAB vs TEGAFUR